Trius Therapeutics, Inc. (TSRX): Are Hedge Funds Right About This Stock?

Page 2 of 2

#N/A

Company Name # of Hedge Funds # of Insiders Buying # of Insiders Selling
NeoGenomics, Inc. (NASDAQ:NEO) 0 0
TearLab Corporation (NASDAQ:TEAR) 3 1 0
China Cord Blood Corp (NYSE:CO) 3 0 1
Nordion Inc (USA) (NYSE:NDZ) 16 0 0
Novadaq Technologies Inc. (NASDAQ:NVDQ) 9 0 0

With the results demonstrated by our strategies, retail investors must always keep an eye on hedge fund and insider trading activity, and Trius Therapeutics, Inc. (NASDAQ:TSRX) applies perfectly to this mantra.

Click here to learn why you should track hedge funds

Page 2 of 2